The Limited Times

Now you can see non-English news...

Covid-19: AstraZeneca suspends clinical trials of its vaccine due to a sick participant

2020-09-09T06:42:26.692Z


One participant suffers from a “potentially unexplained illness”, possibly due to a serious side effect. AstraZeneca is testing its vaccine on tens of thousands of volunteers.


The pharmaceutical group AstraZeneca announced Tuesday, September 8 a pause in clinical trials of its experimental vaccine against Covid-19 after the appearance of a "

potentially unexplained disease

", probably a serious side effect, in a participant.

Read also: "I do not trust": why many French people are suspicious of a vaccine against Covid-19

AstraZeneca is the industrial partner of the UK University of Oxford, and their vaccine is one of the most advanced Western projects, tested on tens of thousands of volunteers in the UK, Brazil, South Africa and since August 31, the United States, in what is called phase 3 of the trials, the last, to verify safety and efficacy.

The affected person should recover

As part of the University of Oxford's global randomized clinical trials of the coronavirus vaccine, our normal assessment process was triggered and we voluntarily paused vaccinations to allow for an assessment of the safety data by an independent committee

, ”a company spokesperson said in a statement.

Read also: Anti-Covid-19 vaccine: Sanofi's race against time

"

This is a routine action that is required as soon as a potentially unexplained disease appears in one of the trials, during the investigation, in order to maintain the integrity of the trials,

" the spokesperson continued.

The nature and severity of the event is unknown, but according to the Statnews website, the affected person is expected to recover.

This is the first known suspension of a clinical trial concerning an experimental vaccine against Covid-19.

Depending on the length of the investigations, this could have an impact on the tight development schedule.

The British Minister of Health had said on Monday that he hoped for results from AstraZeneca's trials by the end of the year or the beginning of 2021. The laboratory has already pre-sold hundreds of millions of doses to multiple countries, in case his vaccine proves its effectiveness.

Source: lefigaro

All tech articles on 2020-09-09

You may like

News/Politics 2024-03-16T18:46:42.470Z

Trends 24h

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.